The wait is finally over for people with diabetes. For years, innovators have been trying to develop a blood glucose monitor that doesn't require pricking your skin. The PreEvnt Isaac is the latest addition to this quest and it's a small device, about the size of a quarter, which you can wear around your neck or keep in your bag.
The PreEvnt Isaac measures volatile organic compounds in your breath to detect biomarkers like acetone that can be correlated with rising blood glucose levels. This means you won't have to visit the bathroom every few minutes to prick your skin and check your sugar levels. The device is also relatively inexpensive, at $399 for a single unit.
The idea behind this technology was born out of necessity after Bud Wilcox's grandson was diagnosed with type 1 diabetes at just two years old. Wilcox realized that "acetone breath" - the sweet, fruity breath that people with diabetes often experience - could be used to check for blood sugar events.
PreEvnt and Wilcox showcased their concept at CES 2025, and later it entered active human clinical trials at Indiana University. The study is comparing Isaac's performance with traditional blood sugar monitoring, starting with adolescents with type 1 diabetes and then expanding to adults with type 2 diabetes.
The device was demoed for the author, who wore it around their neck and took a few deep breaths onto the device. It computed the user's blood sugar levels and logged them into the companion smartphone app. The app also includes features like a log of what you're eating on a timeline, which can help prevent hypoglycemic episodes.
The development of this technology is not without its challenges. Metabolic tracking has become increasingly popular in recent years, with companies monitoring users' food intake and blood sugar levels for peak performance or weight loss. However, the Isaac serves as a reminder that these technologies were initially developed to make a difference in people's lives - particularly those living with diabetes.
The Isaac is set to undergo regulatory review by the US Food and Drug Administration later this year, which could pave the way for its release on the market.
The PreEvnt Isaac measures volatile organic compounds in your breath to detect biomarkers like acetone that can be correlated with rising blood glucose levels. This means you won't have to visit the bathroom every few minutes to prick your skin and check your sugar levels. The device is also relatively inexpensive, at $399 for a single unit.
The idea behind this technology was born out of necessity after Bud Wilcox's grandson was diagnosed with type 1 diabetes at just two years old. Wilcox realized that "acetone breath" - the sweet, fruity breath that people with diabetes often experience - could be used to check for blood sugar events.
PreEvnt and Wilcox showcased their concept at CES 2025, and later it entered active human clinical trials at Indiana University. The study is comparing Isaac's performance with traditional blood sugar monitoring, starting with adolescents with type 1 diabetes and then expanding to adults with type 2 diabetes.
The device was demoed for the author, who wore it around their neck and took a few deep breaths onto the device. It computed the user's blood sugar levels and logged them into the companion smartphone app. The app also includes features like a log of what you're eating on a timeline, which can help prevent hypoglycemic episodes.
The development of this technology is not without its challenges. Metabolic tracking has become increasingly popular in recent years, with companies monitoring users' food intake and blood sugar levels for peak performance or weight loss. However, the Isaac serves as a reminder that these technologies were initially developed to make a difference in people's lives - particularly those living with diabetes.
The Isaac is set to undergo regulatory review by the US Food and Drug Administration later this year, which could pave the way for its release on the market.